PAVmed Inc., incorporated on June 26, 2014, is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo.
PortIO
PortIO is an implantable vascular access device, which does not require accessing the central venous system and does not have an indwelling intravascular component. It provides various access sites and can be used in patients with chronic total occlusion of their central veins. It features near-percutaneous insertion and removal, without the need for surgical dissection or radiographic confirmation.
CarpX
CarpX is a percutaneous device to treat carpal tunnel syndrome. To use its device, the operator first advances a percutaneously placed guidewire through the carpal tunnel under the ligament. Its device is then advanced over the wire and positioned in the carpal tunnel under ultrasonic and/or fluoroscopic guidance. When activated it creates space within the tunnel, confirms that the nerve is protected from the cutting element and divides the ligament. The Company's device may also be applicable to other clinical situations where percutaneous division of a fibrous structure can be used for therapeutic effect, such as plantar fasciitis and extremity compartment syndromes resulting from trauma or ischemia.
NextCath
NextCath is a self-anchoring catheter, which does not require suturing, traditional anchoring techniques or add-on catheter securement devices. The Company is focusing on peripheral venous catheter's (PVC's) and will proceed to central venous catheter's (CVC's) thereafter. Its self-anchoring technique, however, is applicable to most, if not all, short-term catheters. It allows the hub of the catheter to be flat and the tubing to come out eccentrically, or parallel to the skin, improving patient comfort and catheter management.
DisappEAR
The Company's DisappEAR is an Antibiotic-eluting Resorbable Ear Tubes. The Company is engaged in developing and commercializing antibiotic-eluting resorbable ear tubes based on an aqueous silk technology conceived and developed at these institutions.
NextFlo
The Company is engaged in developing disposable infusion system with variable flow resistors. The Company has performed computer simulation testing on various embodiments and has demonstrated flow rates across a range of driving pressures.
Caldus
Caldus is a disposable tissue ablation device. The Company is developing completely disposable tissue ablation devices, including for renal denervation, based on direct thermal ablation of the tissue using heated fluid. Its device uses an infusion device to deliver heated fluid to a specially designed balloon catheter, which heats the target tissue above its cytotoxic threshold according to a specified pattern.
1 Grand Central Terminal Ste 460
The company trades on NASDAQ exchange. The company headquarter is located in New York, NY. The company was established in the 2014.| Ticker | PAVM |
| Long Name | PAVmed Inc. |
| Short Name | PAVmed |